Lactoferricin B

General Information


DRACP ID  DRACP00153

Peptide Name   Lactoferricin B

Sequence  FKCRRWQWRMKKLGAPSITCVRRAF

Sequence Length  25

UniProt ID  P24627 

PubChem CID  Not available

Origin  The big centipede Scolopendra subspinipes mutilans

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Kelly Neuroblastoma Blastoma IC50=15.5 µM MTT assay 48 h 1
IMR-32 Neuroblastoma Blastoma IC50=29 µM MTT assay 48 h 1
SK-N-DZ Neuroblastoma Blastoma IC50=37 µM MTT assay 48 h 1
SHEP-12 Neuroblastoma Blastoma IC50=45 µM MTT assay 48 h 1
SH-SY5Y Neuroblastoma Blastoma IC50=60 µM MTT assay 48 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  LfcinB possesses a cytotoxic effect on MYCN-amplified NB cells by directly targeting and destabilizing the cytoplasmic membrane and the mitochondria.

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  1LFC 

Predicted Structure  DRACP00153

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3 <--> Cys20

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C141H226N46O29S3

Absent amino acids  DEHNY

Common amino acids  R

Mass  355407

Pl  12.35

Basic residues  8

Acidic residues  0

Hydrophobic residues  9

Net charge  8

Boman Index  -6879

Hydrophobicity  -57.6

Aliphatic Index  50.8

Half Life 
  Mammalian:
  Yeast:
  E.coli:

Extinction Coefficient cystines  11125

Absorbance 280nm  463.54

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 16572423

Title  The antimicrobial peptide, lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo

Doi 10.1002/ijc.21886

Year  2006

Literature 2

Pubmed ID 11908643

Title  Towards a structure-function analysis of bovine lactoferricin and related tryptophan- and arginine-containing peptides

Doi 10.1139/o01-213

Year  2002

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.